At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on February 17th, 2023 | 17:05 CET
Rare earth revolution instead of China dependency: BYD, Auxico Resources, American Lithium
China's rise has been long planned. Thanks to strategically aligned five-year plans, the former agricultural state now has a dominant market position in many areas. Examples include the Greentech sector and the business with modern electricity storage systems for electric cars. But alternatives are slowly emerging. Alternatives that also give hope to German industry.
Read
Commented by Nico Popp on February 16th, 2023 | 22:10 CET
Rare earths are increasingly important: Rheinmetall, Defense Metals, Volkswagen
Der Spiegel, Die Welt, Münchner Merkur - in the past week alone, many media reported on the role of rare earths in the energy transition. The conclusion everywhere: rare earths are not rare but urgently needed. Mining sites, therefore, urgently need to be developed - ideally in a sustainable and environmentally friendly way. We focus on three companies in urgent need of rare earths or considered up-and-coming producers.
Read
Commented by Nico Popp on February 15th, 2023 | 12:11 CET
Inflation picks up again! Here is what the figures mean for Mercedes-Benz, Power Nickel and Varta
Inflation rates in the US remain high. Consumer prices rose more than expected in January. For investors, this has several meanings: On the one hand, the spectre of recession is likely to have been dispelled; on the other hand, the US Federal Reserve could continue to turn the interest rate screw. What does this mean for innovative companies involved in the mega-trend of electrification? We provide the answers!
Read
Commented by Nico Popp on February 14th, 2023 | 15:49 CET
Takeover fever around biotechs - Bayer's reaction, purchase candidates BioNxt and Morphosys?
Something is happening in the biotech sector: several global players are looking for potential acquisition targets. Above all, pharmaceutical companies focusing on the US are seeing their chances of survival dwindle in light of the Inflation Reduction Act. If drug prices are to fall, new products must be developed or costs cut elsewhere. We take a look at the industry and do a takeover check.
Read
Commented by Nico Popp on February 10th, 2023 | 12:37 CET
Real estate crash - alternatives to housing: Commerzbank, Alpina Holdings, Hypoport
"Emergency braking" and "The worst is yet to come!" - these or similar are comments on the German real estate market. Although housing is scarce, hardly anyone can afford it. Residential real estate sales are at rock bottom, and new construction plans are being cancelled by the dozen. Are real estate investments at the end? We show flexible alternatives on the stock market without huge purchase costs.
Read
Commented by Nico Popp on February 9th, 2023 | 19:54 CET
Comeback opportunity or a complete washout? These facts decide: Deutsche Bank, K+S, Tocvan Ventures
Various sectors have enjoyed a boom in recent months. Commodity companies benefited from rising prices, and banks from higher interest rates. But the trees do not grow to the sky even for stocks favoured by the market. Every trend comes to an end. Where investors can believe in comebacks and where uneasiness could threaten - we take a close look for you!
Read
Commented by Nico Popp on February 9th, 2023 | 19:47 CET
Banks and their risky gold bets: Credit Suisse, PayPal, Desert Gold
Credit Suisse will publish its quarterly figures on Wednesday, February 15, and answer analysts' questions. The market is looking very closely at the details of the crisis bank, which is in trouble because of the bankruptcy of Greensill Bank and the implosion of a hedge fund in 2021. Now stress is also looming around Credit Suisse's gold exposure. Reason enough to raise awareness of risks and highlight opportunities!
Read
Commented by Nico Popp on February 8th, 2023 | 11:52 CET
Banks bet 5,000 tons of gold - explosive power? Deutsche Bank, Alerio Gold, Commerzbank
Anyone investing in gold is betting on an alternative asset class - the precious metal is seen as a reserve currency in a world dominated by banks and large financial institutions. But as the latest figures show, the role of banks in the gold market may be far greater than thought. In the US alone, more than 5,000t is at stake in bank balance sheets with the potential for dramatic price movements.
Read
Commented by Nico Popp on February 7th, 2023 | 16:16 CET
Are E-cars facing the end? Mercedes-Benz, dynaCERT, NEL
What constitutes mobility is changing. There are also many mobility terms. It is increasingly difficult for automakers to position themselves. Except for BMW, all major manufacturers are now focusing exclusively on battery-powered e-cars. The trend is even so intact for decision-makers at major corporate headquarters that type designations introduced for e-cars are facing extinction. But not all automakers are convinced that e-cars are the way to go.
Read
Commented by Nico Popp on February 2nd, 2023 | 18:04 CET
Bulging pipeline at BioNTech, Cardiol Therapeutics - what is the problem at Aurora Cannabis?
He who heals is right. It is not quite that simple with active ingredients that are about to be approved. Drugs and vaccines must undergo extensive studies and, last but not least, have to prevail against the existing competition. We look at the pipelines of three hot stocks and venture a forecast: Where is the greatest potential for investors?
Read